Board members from The Norwegian Cancer Society visited Oslo Cancer Cluster Innovation Park and toured expanded facilities at Radium Hospital and learned about Oslo Cancer Cluster’s public-private partnership initiatives in cancer research. During the visit, they met with Oncosyne’s CEO Jarle Bruun who demonstrated the company’s cutting-edge lab spaces where they are developing world-leading predictive tumoroid drug screening tools.
